M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells

Nicole N. van der Wel, David L. Hava, Donna Fluitsma, +4

Cell

Pulmonary TuberculosisM. TuberculosisGranulocyteImmunologyTuberculosis +6

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg, +53

New England Journal of Medicine

ESX‐1‐mediated translocation to the cytosol controls virulence of mycobacteria

Caroline Demangel, Jakko van Ingen, Jorge Pérez, +15

Cellular Microbiology

Pathogenic MicrobiologyMicrobial PathogensBacteriologyImmunologyBacterial Pathogens +14

Direct Visualization by Cryo-EM of the Mycobacterial Capsular Layer: A Labile Structure Containing ESX-1-Secreted Proteins

Musa Sani, Edith N. G. Houben, Jeroen Geurtsen, +11

PLoS Pathogens

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up

Joost H. van den Berg, Bianca Heemskerk, Nienke van Rooij, +21

Journal for ImmunoTherapy of Cancer

Mycobacterial Secretion Systems ESX-1 and ESX-5 Play Distinct Roles in Host Cell Death and Inflammasome Activation

Abdallah M. Abdallah, Jovanka Bestebroer, Nigel D. L. Savage, +9

The Journal of Immunology

Microbial PathogensInflammasome ActivationInnate Immune SystemImmunologyImmune Regulation +25

The ESX-5 Secretion System of <i>Mycobacterium marinum</i> Modulates the Macrophage Response

Abdallah M. Abdallah, Nigel D. L. Savage, Maaike van Zon, +5

The Journal of Immunology

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells

Elisa Matas-Rico, Elselien Frijlink, Irene van der Haar Àvila, +16

Cell Reports

Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation

David L. Hava, Nicole N. van der Wel, Nadia Cohen, +9

Proceedings of the National Academy of Sciences

Plasma MembraneAdaptive Immune SystemPathogenesisImmunologyDc Maturation +12

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial

Maartje W. Rohaan, Raquel Gomez-Eerland, Joost H. van den Berg, +25

Immuno-Oncology Technology